Glucksmann Alexandra 4
4 · REGENXBIO Inc. · Filed May 30, 2018
Insider Transaction Report
Form 4
REGENXBIO Inc.RGNX
Glucksmann Alexandra
Director
Transactions
- Award
Stock Option (Right to Buy)
2018-05-25+25,000→ 25,000 totalExercise: $49.45Exp: 2028-05-25→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option will vest in equal monthly installments over the 36 months following May 25, 2018, with immediate full vesting in the event of a change in control.